Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Goirand

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Pharmacology & Physiology|March 4, 2005
Effect of dietary docosahexaenoic acid on the endothelium-dependent vasorelaxation in diabetic ratsFrançoise Goirand, Stéphanie Ovide-Bordeaux, Jean-François Renaud, et al.
Journal of Cardiovascular Pharmacology|December 25, 2002
ETA, mixed ETA/ETB receptor antagonists, and protein kinase C inhibitor prevent acute hypoxic pulmonary vasoconstriction: influence of potassium channelsFrançoise Goirand, Marc Bardou, Pascal Guerard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 15, 2006
The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatinZo Rakotoniaina, Pascal Guerard, Frederic Lirussi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 11, 2008
Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the ratZo Rakotoniaina, Pascal Guerard, Frédéric Lirussi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 10, 2006
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOSPascal Guerard, Zo Rakotoniaina, Françoise Goirand, et al.
International Journal of Molecular Sciences|September 10, 2021
Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung DiseasesJulie Tanguy, Lenny Pommerolle, Carmen Garrido, et al.
European Journal of Pharmacology|October 7, 2004
Arachidonic acid relaxes human pulmonary arteries through K+ channels and nitric oxide pathwaysPascal Guerard, Françoise Goirand, Nicolas Fichet, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 20, 2018
How can we best monitor 5-FU administration to maximize benefit to risk ratio?Françoise Goirand, Florian Lemaitre, Manon Launay, et al.
Biochimie|October 8, 2011
Postnatal overfeeding in rats leads to moderate overweight and to cardiometabolic and oxidative alterations in adulthoodAhmed Habbout, Stephanie Delemasure, Françoise Goirand, et al.
The Journal of Nutrition|March 31, 2004
Vitamin C deficiency exerts paradoxical cardiovascular effects in osteogenic disorder Shionogi (ODS) ratsCatherine Vergely, Françoise Goirand, Aline Ecarnot-Laubriet, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Pharmacology & Physiology|March 4, 2005
Effect of dietary docosahexaenoic acid on the endothelium-dependent vasorelaxation in diabetic ratsFrançoise Goirand, Stéphanie Ovide-Bordeaux, Jean-François Renaud, et al.
Journal of Cardiovascular Pharmacology|December 25, 2002
ETA, mixed ETA/ETB receptor antagonists, and protein kinase C inhibitor prevent acute hypoxic pulmonary vasoconstriction: influence of potassium channelsFrançoise Goirand, Marc Bardou, Pascal Guerard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 15, 2006
The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatinZo Rakotoniaina, Pascal Guerard, Frederic Lirussi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 11, 2008
Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the ratZo Rakotoniaina, Pascal Guerard, Frédéric Lirussi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 10, 2006
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOSPascal Guerard, Zo Rakotoniaina, Françoise Goirand, et al.
International Journal of Molecular Sciences|September 10, 2021
Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung DiseasesJulie Tanguy, Lenny Pommerolle, Carmen Garrido, et al.
European Journal of Pharmacology|October 7, 2004
Arachidonic acid relaxes human pulmonary arteries through K+ channels and nitric oxide pathwaysPascal Guerard, Françoise Goirand, Nicolas Fichet, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 20, 2018
How can we best monitor 5-FU administration to maximize benefit to risk ratio?Françoise Goirand, Florian Lemaitre, Manon Launay, et al.
Biochimie|October 8, 2011
Postnatal overfeeding in rats leads to moderate overweight and to cardiometabolic and oxidative alterations in adulthoodAhmed Habbout, Stephanie Delemasure, Françoise Goirand, et al.
The Journal of Nutrition|March 31, 2004
Vitamin C deficiency exerts paradoxical cardiovascular effects in osteogenic disorder Shionogi (ODS) ratsCatherine Vergely, Françoise Goirand, Aline Ecarnot-Laubriet, et al.
Pageof 4